BPC
ENTA icon

Banque Pictet & Cie’s Enanta Pharmaceuticals ENTA Stock Holding History

Banque Pictet & Cie’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,594
Closed -$469K – 530
2023
Q1 		$469K Sell
11,594
-5,257
-31% -$251K ﹤0.01% 471
2022
Q4 		$784K Sell
16,851
-5,317
-24% -$242K 0.01% 432
2022
Q3 		$1.15M Buy
+22,168
New +$1.3M 0.01% 371

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Banque Pictet & Cie's ENTA Position: Q2 2023 in Review

Banque Pictet & Cie sold out of Enanta Pharmaceuticals (ENTA) in Q2 2023, closing a stake of 11,594 shares — an estimated $469K sold.

Banque Pictet & Cie first reported a position in ENTA in Q3 2022 and held it in 3 quarters. The position peaked at $1.15M in Q3 2022. 133 funds tracked by Wall St. Rank hold ENTA as of Q2 2023.

  • Banque Pictet & Cie reported no remaining Enanta Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Banque Pictet & Cie sold 11,594 Enanta Pharmaceuticals shares in Q2 2023, an estimated $469K.
  • Banque Pictet & Cie first reported a position in Enanta Pharmaceuticals in Q3 2022 and held it in 3 quarters.
  • Banque Pictet & Cie's Enanta Pharmaceuticals position peaked at $1.15M in Q3 2022.
  • 133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2023.

Based on Banque Pictet & Cie's 13F filing for Q2 2023, filed 4 Aug 2023.